Telehealth providers in North Carolina
By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed. Last verified
Telehealth prescribing is allowed in North Carolina, including asynchronous care. What North Carolina requires of telehealth prescribers and pharmacies, plus listings with their verification status.
North Carolina at a glance
- Pharmacy regulator
- North Carolina Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async allowed
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Telehealth providers serving North Carolina
Prescription peptides through an online assessment and a licensed provider review, shipped from a licensed U.S. compounding pharmacy.
Telehealth provider · 17 products · partner lists from $172 a month · Says it serves North Carolina (not yet confirmed)
- Prescription only, no research-use-only sales
- Public cancellation and refund policy
We may earn a commission from these links.
Telehealth prescribing rules in North Carolina
North Carolina regulates telemedicine prescribing mainly through North Carolina Medical Board Position Statement 5.1.4 (Telemedicine, amended March 2024) rather than a practice statute. The Board says a licensee-patient relationship may be established through either synchronous or asynchronous telemedicine technologies without a prior in-person meeting, so long as the standard of care is met, and that licensees may use their judgment to prescribe as part of a telemedicine encounter. It also says diagnosis or prescribing based solely on static online questionnaires is not acceptable, and that licensees who use questionnaires should be able to ask follow-up questions. Position Statement 4.1.1 adds that prescribing to someone the licensee has never met based solely on answers to a set of questions is unprofessional. Telemedicine-only care may be unsuitable in some cases, including the treatment of pain. The prescriber must hold a North Carolina license. None of the peptides in this database are controlled substances. This record classifies asynchronous prescribing as allowed because the Board's position statement in force today expressly permits asynchronous technology to establish the relationship and permits prescribing, while barring questionnaire-only prescribing. A position statement is board policy, not a rule. [2] [3]
Compounded GLP-1 access in North Carolina
Any out-of-state pharmacy shipping compounded GLP-1s in must hold an annual G.S. 90-85.21A registration. [4] [10]
Research use only sellers in North Carolina
The North Carolina Food, Drug, and Cosmetic Act (G.S. 106-120 and following) prohibits selling adulterated or misbranded drugs, and the Pharmacy Practice Act restricts dispensing of legend drugs to permitted pharmacies. [5] [8] [11]
How to check a telehealth provider in North Carolina
- Confirm the prescriber is licensed or registered to treat patients located in North Carolina; the telehealth rules above explain what North Carolina requires. [2] [3]
- Ask which pharmacy will fill the prescription and check it in the North Carolina Board of Pharmacy license lookup. [1] [4] [5] [6] [7] [9]
- Get the full price in writing first: consult fees, membership fees, and the medication itself.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in North Carolina. [5] [8] [11]
Common questions in North Carolina
Does North Carolina have a telehealth statute?
Not a general practice statute. North Carolina relies on the Medical Board's telemedicine position statement and general licensing law, so the standard of care governs what evaluation is needed before prescribing. The position statement allows synchronous or asynchronous telemedicine to establish the relationship, but it says prescribing based solely on static online questionnaires is not acceptable. [2]
Sources
- [1]North Carolina Board of Pharmacy
- [2]North Carolina Medical Board Position Statement 5.1.4, Telemedicine
- [3]North Carolina Medical Board Position Statement 4.1.1, Contact With Patients Before Prescribing
- [4]N.C. G.S. 90-85.21A, Pharmacies outside North Carolina (nonresident registration)
- [5]N.C. G.S. Chapter 90, Article 4A, North Carolina Pharmacy Practice Act
- [7]North Carolina Board of Pharmacy: General pharmacy FAQs (compounding GLP-1s and semaglutide)
- [8]N.C. G.S. Chapter 106, Article 12, Food, Drug, and Cosmetic Act
- [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [11]21 U.S.C. 331, Prohibited acts